We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Discovery to Provide Access to Novel Base Editing Technology

Product News   Jan 15, 2020

 
Horizon Discovery to Provide Access to Novel Base Editing Technology
FURTHER INFORMATION
 
 
 

Related Product News

Horizon Licenses Use of GS Knockout CHO K1 Cell Line to NGM Bio

Product News

Horizon has announced that it will license its gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line to NGM Biopharmaceuticals.

READ MORE

Horizon Discovery and Mammoth Biosciences Collaborate To Improve Biotherapeutic Production

Product News

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

READ MORE

Enterprise Publish Novel Therapeutic Approach for Cystic Fibrosis Patients

Product News

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company aimed towards the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, has announced the publication of its first peer-reviewed paper.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE